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Approximately 645 people suffer from blunt force trauma injury to the femur every day. The recovery 
time of such injury can last anywhere from 3-6 months. Thrombopoietin (TPO) was used as a growth 
factor to induce bone and muscle healing. In this study we utilized 9 separate mouse model groups (10 
mice per group) were used: Crush PBS, Crush TPO, Surgery PBS, and Surgery TPO at day 3 and day 17, 
and controls with no surgery/crush/ treatment. Crush models were introduced to hind limb crush injury by 
a mechanical-gravity driven Einhorn device. Skeletal muscle was harvested from the following sites: 
experimental impact, experimental adjacent, and normal contralateral skeletal muscle as a control. The 
muscles were fixed, processed, sectioned, and stained with H&E and Masson’s Trichrome stains. The 
slides were reviewed for skeletal muscle injury, muscle necrosis, inflammation, muscle repair, and 
regeneration. In addition, F4/80, an immunostain for macrophages was performed. On microscopic 
examination at day 3 the most common histologic changes seen were sporadic muscle fiber vacuolation, 
focal necrosis of varying sizes, muscle contraction bands, and infiltration of macrophages. On day 17, the 
skeletal muscle injury was generally healed. The main histologic lesions seen were variable sizes of 
muscle fibers, early fibroplasia, fat infiltration, some macrophages( less than day 3) , satellite cells, and 
neovascularization. A follow-up immunostain (CD206 specific for M2 double labeled with F4/80) was 
performed to characterize the macrophages in and around the lesions at day 3. M2 macrophages were 
seen around the periphery of the lesion and none in the middle of the lesion.  There were very minimal 
differences in M2 numbers between the PBS and TPO treated groups at day 3. In conclusion, comparing 
the TPO treated mice versus the PBS control group with F4/80 immunostain showed the lesions at both 
time points were less in the TPO treated mice. 
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